(Fighting against New Coronary Pneumonia) Zhong Nanshan: China's vaccine development is at the forefront of the world
China News Service, Guangzhou, April 28 (Cai Minjie) Zhong Nanshan, an academician of the Chinese Academy of Engineering, said in an industry development forum held in Guangzhou on the 28th that the new crown epidemic situation said that China had done well in the first phase of the epidemic To prevent the importation of overseas cases, "Our vaccine research process is developing very fast, at least in the world, it is at the forefront, and it can protect more people from new coronary pneumonia."
There are currently over 3 million confirmed cases of new coronary pneumonia in the world, and more than 200,000 people have died. Zhong Nanshan said, "Now it seems that the number of cases in some countries is still high. So for us, it is a very difficult time."
Zhong Nanshan said that in the first phase, everyone will implement the “early protection, early detection, early treatment and early isolation” measures of the community; but now in many countries and regions, 5 or 6 weeks have passed, and the epidemic has been hovering at a high level. He believes that only when the number of cases in the world or major countries starts to decline, can people's health be more protected.
On the same day, Guangyao Group donated medicine worth RMB 1 million to the Red Cross Society of Guizhou Province through the Zhongnanshan Foundation to strengthen the later prevention and control of the epidemic. Zhong Nanshan stated that he had lived in Guizhou for many years and hoped to explore more ways to improve the living standard of people in Qiannan of Guizhou Province. (Finish)